Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment

被引：0
|
作者：
Rafael Morales-Barrera
Guillermo Villacampa
Natalia Vidal
Mariona Figols
Julia Giner
Teresa Bonfill
Cristina Suárez
Nely Díaz
Joaquín Mateo
Macarena González
Montserrat Domenech
Javier Puente
Joan Carles
机构：
[1] Vall d’Hebron Institute of Oncology,Department of Medical Oncology
[2] Vall d’ Hebron University Hospital,Oncology Data Science (OdysSey) Group
[3] Universitat Autònoma de Barcelona,Medical Oncology Department
[4] Vall d’Hebron Institute of Oncology (VHIO),Medical Oncology Department
[5] The Institute of Cancer Research,Medical Oncology
[6] Hospital Clínico San Carlos,undefined
[7] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[8] CIBERONC,undefined
[9] Fundació Althaia Manresa,undefined
[10] Parc Taulí Hospital Universitari,undefined
[11] Institut d’Investigació i Innovació Parc Taulí I3PT,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Immune checkpoint inhibitors; Immune-related adverse events; Overall response rate; Survival; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3556 / 3564
页数：8
相关论文
共 50 条
  • [31] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [32] The effect of antibiotic use on immune-checkpoint inhibitor efficacy in patients with advanced urothelial carcinoma.
    Khan, Mohammad
    Radakovich, Nathan
    Rini, Brian, I
    Mian, Omar Y.
    Ornstein, Moshe Chaim
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Pancreatic Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy
    Patel, Vanisha
    Ashkar, Motaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S714 - S714
  • [34] Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy
    Saliba, Antoine N.
    Xie, Zhuoer
    Higgins, Alexandra S.
    Andrade-Gonzalez, Xavier A.
    Fuentes-Bayne, Harry E.
    Hampel, Paul J.
    Kankeu Fonkoua, Lionel A.
    Childs, Daniel S.
    Rakshit, Sagar
    Bezerra, Evandro D.
    Kommalapati, Anuhya
    Lou, Yanyan
    Rivera, Candido E.
    Price, Katharine A.
    Chintakuntlawar, Ashish
    Yan, Yiyi
    Schwecke, Anna J.
    Block, Matthew S.
    Thanarajasingam, Uma
    Thanarajasingam, Gita
    Wolanskyj-Spinner, Alexandra P.
    Marshall, Ariela L.
    Kottschade, Lisa A.
    Go, Ronald S.
    Al-Kali, Aref
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : E362 - E367
  • [35] Factors Associated with Immune-Related Adverse Events in Immune Checkpoint Inhibitor Users
    Jung, Sun-Young
    Nam, Dal Ri
    Jung, Yu-Seon
    Lee, Jongmin
    Kim, Eunji
    DRUG SAFETY, 2024, 47 (12) : 1426 - 1426
  • [36] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [37] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Zheng, Shu-Yue
    Duan, Hua
    Cui, Hui-Juan
    JAMA ONCOLOGY, 2020, 6 (11) : 1813 - 1813
  • [38] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [39] Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
    Shao, Jun
    Wang, Chengdi
    Ren, Pengwei
    Jiang, Yuting
    Tian, Panwen
    Li, Weimin
    BIOSCIENCE REPORTS, 2020, 40
  • [40] Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
    Les, Inigo
    Martinez, Mireia
    Perez-Francisco, Ines
    Cabero, Maria
    Teijeira, Lucia
    Arrazubi, Virginia
    Torrego, Nuria
    Campillo-Calatayud, Ana
    Elejalde, Inaki
    Kochan, Grazyna
    Escors, David
    CANCERS, 2023, 15 (05)
12345